Summary
  • Multi-target molecules 85
  • Clinical molecules 0
  • Avg pChEMBL 6.62
Top Co-occurrence Targets
Active Molecules (85)
InChIKey pChEMBL Type Targets Clinical
YPFWNRLSYPAVJB 8.1 Ki 2
JBLLRCOZJMVOAE 8.0 Kd 2
ZMUQNKRTLPRFGB 7.8 IC50 2
RBWMYPKAPIYTJQ 7.8 IC50 2
XLUYKDBBKIMNQG 7.7 Ki 2
ODGRTWPIJBYMDL 7.6 Ki 2
FHPKLFZHYVJFDO 7.5 Ki 2
NTHJYOHUJPHCJD 7.5 Ki 2
QRTUECBYTYJXHL 7.5 IC50 2
KOUVVHAGIUSYCU 7.3 IC50 2
BSPZFJDYQHDZNR 7.3 IC50 7
HMICIXHTRIFAET 7.3 IC50 2
BRLBTOJQLXGOHO 7.3 IC50 2
HPKJGHVHQWJOOT 7.3 IC50 2
XUHFZJPQDLAZMY 7.3 IC50 2
YFUZVOLEKQFVCQ 7.3 Ki 3
YFUZVOLEKQFVCQ 7.3 Ki 5
PWBQMVUCCVWDEJ 7.2 Ki 2
DWJOEJDGHVXXEB 7.2 IC50 3
UICFGOSRHHZBHZ 7.2 IC50 2
JMBJZTHVHMZAKN 7.2 Ki 2
LJTINUKMKJKLBT 7.2 IC50 2
SENRSUXIIOUWCL 7.2 IC50 3
PEWPQJNFKWMXCQ 7.2 Ki 2
QYENXTYKACLCGO 7.2 IC50 2
MNUHXGJUYTWVLU 7.0 IC50 2
WSVWWSLUPXQXHY 7.0 IC50 2
LLMHUZNGBKKMAA 6.9 Ki 2
KRKZTFZXGIMFRZ 6.8 Ki 2
BSPZFJDYQHDZNR 6.8 IC50 4
QNRLUURSWJCRAA 6.8 IC50 2
QHBWMDVARYUYJW 6.8 IC50 2
CSEAAOWXHPFATP 6.6 IC50 2
INAZPZCJNPPHGV 6.5 IC50 2
IVXBCFLWMPMSAP 6.5 IC50 2
FHKJMYCHKVBRQO 6.5 Ki 2
WYPAHDOIQYCGQI 6.5 Ki 2
UIXQHURPUVBNCZ 6.5 IC50 2
IGVYCVBUHQMNRZ 6.4 IC50 2
XOTUFJPCITWJHW 6.4 IC50 2
REYMLCFMQQQRLG 6.4 Ki 2
RKPRAVWHLWEYOD 6.4 Ki 2
PEWBNHRXKXFYKA 6.4 Kd 2
AJRQIXBBIDPNGK 6.3 Ki 2
BIKTWHWUIKAJAT 6.3 IC50 2
DBZLJJMKJAMBRF 6.3 IC50 2
PAVJYVVZIJTAHT 6.3 IC50 2
MJNVJROJBPZTOE 6.3 IC50 2
GIQUHGHOCMQIGO 6.2 Ki 2
KGPYBLOBHQLIET 6.2 IC50 2
2D structure